Nature's Twin
Plant-Identical Cannabinoids for Your Health and Wellness Products
We produce rare cannabinoids that are molecularly identical to those found in the Cannabis plant at industry-leading purity and scalability. Our processes allow us to create these bioidentical compounds—including Tetrahydrocannabivarin (THCV), Cannabidivarin (CBDV), Cannabichromene (CBC), and the ultra-rare Cannabicitran (CBT)—at commercial scale with unprecedented consistency and quality. Health and wellness product manufacturers can now access these highly pure, bulk rare cannabinoids in any quantity, opening up new possibilities for innovative formulations without limitations.
.
Minor Cannabinoids
Cannabichromene
Cannabichromene (CBC) is non-intoxicating cannabinoid that is believed to function by binding the CB2 receptor as well as the vanilloid receptor 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1). The result of engaging these receptors is increased levels of natural endocannabinoids that are known to have positive effects on many body systems.
Tetrahydrocannabivarin
Tetrahydrocannabivarin (THCV) is a minor cannabinoid and recognized as non-intoxicating. THCV has been shown to act as an antagonist of CB1 receptors of the endocannabinoid system as well as other endogenous receptors including GPR55 and TRPV1. THCV has been the subject of much clinical and nonclinical research into its physiological effects, with most of the research focused on studying its appetite suppressive effects.
Cannabidivarin
Cannabidivarin (CBDV), is a non-intoxicating compound found in C. sativa, but unlike cannabidiol (CBD), CBDV is produced in very small amounts in hemp. CBDV has been shown to act through binding of various receptors including the ankryin-type receptor TRPA1 and vanilloid-type, TRPV1 and TRPV2 receptors. Like other CB2 agonists, CBDV is believed to produce a number of positive effects by engaging the Endocannabinoid System.
Cannabicitran
Cannabicitran (CBTC) is an ultra-rare cannabinoid found in the cannabis plant and is recognized as a non-intoxicating cannabinoid. CBTC was discovered and isolated from Lebanese Cannabis sativa in 1974.
Pioneering Access to Rare Cannabinoids
The cannabis plant contains over a hundred rare cannabinoids beyond THC and CBD, each with unique characteristics and potential physiological effects. Emerging research suggests these minor cannabinoids may offer superior benefits for certain applications compared to THC and CBD. However, their scarcity in the plant has made them impractical and expensive to extract and separate from plant-derived material.
We’ve solved this challenge by pioneering food-grade cGMP chemical synthesis and biosynthesis techniques to produce these valuable compounds efficiently and at scale. This breakthrough allows us to offer a wide range of pure, rare cannabinoids for innovative product development.
Interested in learning more about the scientific research on rare cannabinoids?
From Compassion to Innovation
Our journey began when co-founder Dr. Shane Johnson sought to help an ailing neighbor, sparking a deep passion for cannabinoid research. Initially cultivating cannabis in a regulated environment, Dr. Johnson soon recognized the limitations of traditional agriculture in terms of quality, consistency, cost, and efficiency. This realization led him to collaborate with pharmaceutical and scientific experts in biosynthesis and synthetic chemistry to develop bioidentical cannabinoids. Today, we’ve successfully scaled the production of rare cannabinoids like D9-THCV, CBDV, CBC, and CBT, combining scientific rigor with a commitment to advancing cannabinoid-based solutions.
From Lab to Large-Scale
We’ve mastered the creation and large-scale production of rare, minor cannabinoids. Our advanced manufacturing techniques ensure consistent high quality and purity, meeting the exacting health and wellness industry standards. All our products undergo rigorous quality control testing and third-party certification. As your preferred supplier of bulk rare cannabinoid ingredients, we offer the flexibility to create custom formulations. By precisely combining ratios of cannabinoids to produce synergistic “entourage” or “potentiation” effects, you can enhance the potential benefits of your health and wellness products with consistent and repeatable formulations.
We don’t touch the plant
Our innovative approach to producing cannabinoids addresses the challenges of large-scale production for certain rare cannabinoids. We use advanced pharmaceutical-grade reactors and employ biosynthesis and /or traditional synthesis methods to produce rare cannabinoids with purity and scalability that are difficult and costly to achieve through other methods.
Our production methods ensure batch-to-batch consistency and purity, free from mold, heavy metals, and other contaminants. Each batch undergoes two rounds of rigorous third-party testing, guaranteeing consistent quality and potency that meets the high standards of health and wellness consumers.
By choosing our ingredients, you’ll access premium-quality cannabinoids and support a sustainable and reliable supply chain solution. Our approach provides a practical and scalable alternative, making us the ideal partner for companies that create cutting-edge health and wellness products.
How to order BayMedica rare, minor cannabinoids
Interested in purchasing wholesale d9-THCV, CBDV, CBC or CBTC for your health and wellness products? Reach out to our distribution partners
.